Cargando…

Evodiamine suppresses non-small cell lung cancer by elevating CD8(+) T cells and downregulating the MUC1-C/PD-L1 axis

BACKGROUND: Accumulating evidence showed that regulating tumor microenvironment plays a vital role in improving antitumor efficiency. Programmed Death Ligand 1 (PD-L1) is expressed in many cancer cell types, while its binding partner Programmed Death 1 (PD1) is expressed in activated T cells and ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Ze-Bo, Huang, Ju-Min, Xie, Ya-Jia, Zhang, Yi- Zhong, Chang, Chan, Lai, Huan-Ling, Wang, Wenjun, Yao, Xiao-Jun, Fan, Xing-Xing, Wu, Qi-Biao, Xie, Chun, Wang, Mei-Fang, Leung, Elaine Lai-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677782/ https://www.ncbi.nlm.nih.gov/pubmed/33208183 http://dx.doi.org/10.1186/s13046-020-01741-5

Ejemplares similares

Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer
por: Li, Jia-Xin, et al.
Publicado: (2019)

Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells
por: Wang, Kai-Lee, et al.
Publicado: (2013)

Peripheral blood T lymphocytes are downregulated by the PD-1/PD-L1 axis in advanced gastric cancer
por: Zgodzinski, Witold, et al.
Publicado: (2018)

Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway
por: Guo, Xing-Xian, et al.
Publicado: (2018)

The Protective Effect of Evodiamine in Osteoarthritis: An In Vitro and In Vivo Study in Mice Model
por: Xian, Shuyuan, et al.
Publicado: (2022)

Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
por: Fang, Jun, et al.
Publicado: (2023)

PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy
por: Huang, Min, et al.
Publicado: (2022)

STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway
por: Xu, Shanshan, et al.
Publicado: (2018)

Binding Mode Prediction of Evodiamine within Vanilloid Receptor TRPV1
por: Wang, Zhanli, et al.
Publicado: (2012)

Gene regulation analysis of the effects of evodiamine on tongue squamous cell carcinoma
por: Wu, Yuyan, et al.
Publicado: (2019)

Evodiamine Induces Apoptosis and Enhances TRAIL-Induced Apoptosis in Human Bladder Cancer Cells through mTOR/S6K1-Mediated Downregulation of Mcl-1
por: Zhang, Tao, et al.
Publicado: (2014)

Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy
por: Huang, Jumin, et al.
Publicado: (2022)

Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer
por: Zhou, Peng, et al.
Publicado: (2019)

Anti-Proliferative Effects of Evodiamine in Human Lung Cancer Cells
por: Hong, Ji-Young, et al.
Publicado: (2014)

Inhibitory effects of evodiamine on human osteosarcoma cell proliferation and apoptosis
por: BAI, XIAODONG, et al.
Publicado: (2015)

Pharmacological Actions of Multi-Target-Directed Evodiamine
por: Yu, Hui, et al.
Publicado: (2013)

Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas
por: Do, Sung-Im, et al.
Publicado: (2013)

Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives
por: Hu, Xu, et al.
Publicado: (2018)

Evaluation of the Cardiotoxicity of Evodiamine In Vitro and In Vivo
por: Yang, Weifeng, et al.
Publicado: (2017)

Preventive Effects of Evodiamine on Dexamethasone-Induced Osteoporosis in Zebrafish
por: Yin, Heng, et al.
Publicado: (2019)

Activation of JNK Contributes to Evodiamine-Induced Apoptosis and G(2)/M Arrest in Human Colorectal Carcinoma Cells: A Structure-Activity Study of Evodiamine
por: Chien, Chih-Chiang, et al.
Publicado: (2014)

Impact of MUC1 Mucin Downregulation in the Phenotypic Characteristics of MKN45 Gastric Carcinoma Cell Line
por: Costa, Natália R., et al.
Publicado: (2011)

Effect of Evodiamine on Collagen-Induced Platelet Activation and Thrombosis
por: Yang, Xiaona, et al.
Publicado: (2022)

Enhanced transdermal delivery of evodiamine and rutaecarpine using microemulsion
por: Zhang, Yong-Tai, et al.
Publicado: (2011)

Preparation of Evodiamine Solid Dispersions and Its Pharmacokinetics
por: Xu, H., et al.
Publicado: (2011)

Airborne particulate matter increases MUC5AC expression by downregulating Claudin-1 expression in human airway cells
por: Kim, Sang-Su, et al.
Publicado: (2017)

Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells
por: Li, Yumei, et al.
Publicado: (2018)

Pharmacological Basis for the Use of Evodiamine in Alzheimer’s Disease: Antioxidation and Antiapoptosis
por: Zhang, Yongfeng, et al.
Publicado: (2018)

Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer
por: Mussafi, Ofek, et al.
Publicado: (2022)

Evodiamine Attenuates PDGF-BB-Induced Migration of Rat Vascular Smooth Muscle Cells through Activating PPARγ
por: Ge, Xie, et al.
Publicado: (2015)

Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
por: Wang, Yiting, et al.
Publicado: (2020)

MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
por: Gao, Lanlan, et al.
Publicado: (2019)

Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer
por: Seshacharyulu, Parthasarathy, et al.
Publicado: (2014)

MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3′UTR and predicts poor survival in non-small cell lung cancer
por: Duan, Fu-Gang, et al.
Publicado: (2019)

Evodiamine inhibits vasculogenic mimicry in HCT116 cells by suppressing hypoxia-inducible factor 1-alpha-mediated angiogenesis
por: Zeng, Di, et al.
Publicado: (2021)

Downregulation of the PD-1/PD-Ls pathway in peripheral cells correlates with asbestosis severity
por: Qiu, Meihua, et al.
Publicado: (2021)

Unlike PD-L1, PD-1 Is Downregulated on Partial Immune Cells in Type 2 Diabetes
por: Sun, Peng, et al.
Publicado: (2019)

Dietary Evodiamine Inhibits Atherosclerosis-Associated Changes in Vascular Smooth Muscle Cells
por: Zha, Yiwen, et al.
Publicado: (2023)

Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer
por: Zhou, Li, et al.
Publicado: (2021)

Evodiamine reduced peripheral hypersensitivity on the mouse with nerve injury or inflammation
por: Zhang, Wen-Dong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dg60c58v1o3314o9qr9i2ebtpo